A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. | NobleBlocks
Public
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
N
Shared by NobleBlocks on May 25, 1989 • 12:00 AM UTC
